Search All News
An experimental immunotherapy improved one-year survival, as compared to historical rates, in a small trial of patients with advanced uveal melanoma.
Neuroscientist Carol Mason, PhD, was elected to the National Academy of Sciences along with 104 other new members and foreign associates.
Columbia Ophthalmology's new tele-ophthalmology van will screen, free of charge, 2,000 NYC residents each year for major sight-threatening conditions.
- August 18, 2017
CUMC ophthalmologist Tongalp Tezel has tips to protect your vision during a solar eclipse, including why taking a selfie with the sun is a bad idea.
- May 30, 2017
Researchers report that CRISPR-Cas9 gene-editing technology can introduce hundreds of unintended mutations into the genome.
- April 19, 2017
New genetic findings should help researchers uncover how MacTel, a disease of the retina, develops and how to design therapies to prevent loss of vision.
- November 14, 2016
Columbia University researchers slowed vision loss in mice who have a form of retinitis pigmentosa by reprogramming the metabolism of photoreceptors in the retina.
- January 27, 2016
Scientists have used a new gene-editing technology called CRISPR, to repair a genetic mutation responsible for vision loss in patient-derived stem cells.
- November 5, 2015
Eye damage from high-power lasers can masquerade as genetic eye diseases and lead to costly work-ups, Columbia ophthalmologists find.
- June 1, 2015
A rare eye disorder marked by color blindness, light sensitivity, and other vision problems can result from a newly discovered gene mutation identified by an international research team, including scientists from Columbia University Medical Center (CUMC). The findings could lead to new, targeted treatments for this form of color blindness.
- July 10, 2014
Columbia University Medical Center researchers have created a way to develop personalized gene therapies for patients with retinitis pigmentosa, a leading cause of vision loss.